Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ropivacaine

A long-acting amide local anaesthetic, developed in Sweden and approved in 1996, used for epidural anaesthesia, nerve blocks and postoperative pain control. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.

Did you know?It is the middle sibling of two older anaesthetics: it carries a propyl group on the nitrogen, between the methyl of mepivacaine and the butyl of bupivacaine. Only its S form, a single enantiomer, is used.

RopivacaineGo to the active ingredient →
RopivacaineActive ingredientRopivacaineCat. No. P-R086-001CAS 84057-95-4
Ropivacaine-d7Isotopically labelledRopivacaine-d7Cat. No. P-R086-014CAS 684647-62-9

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.